These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 23945441

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA, Rehders A, Haeberle L, Fung S, Lehwald N, Esposito I, Ziayee F, Krieg A, Knoefel WT, Fluegen G.
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH.
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
    Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T.
    World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N, Fukunaga T, Kimura M, Sugamoto Y, Tasaki K, Hoshino I, Ota T, Maruyama T, Tamachi T, Hosokawa T, Asai Y, Matsubara H.
    World J Gastroenterol; 2015 Nov 28; 21(44):12722-8. PubMed ID: 26640350
    [Abstract] [Full Text] [Related]

  • 10. [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasis].
    Otake H, Takizawa K, Nagaro H, Toge K, Hirose Y, Ishikawa H, Miura K, Ichikawa H, Hanyu T, Nagahashi M, Shimada Y, Ishikawa T, Sakata J, Kobayashi T, Wakai T.
    Gan To Kagaku Ryoho; 2021 Dec 28; 48(13):2002-2004. PubMed ID: 35045474
    [Abstract] [Full Text] [Related]

  • 11. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
    Hirono S, Kawai M, Okada KI, Miyazawa M, Kitahata Y, Kobayashi R, Hayami S, Ueno M, Yamaue H.
    Eur J Surg Oncol; 2021 Oct 28; 47(10):2586-2594. PubMed ID: 34127329
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S, Choi DW, Choi SH, Heo JS, Han IW, You YH.
    Asian J Surg; 2021 Jan 28; 44(1):313-320. PubMed ID: 32972828
    [Abstract] [Full Text] [Related]

  • 13. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.
    Eur J Surg Oncol; 2012 Apr 28; 38(4):333-9. PubMed ID: 22317758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.
    Doi R, Kami K, Ito D, Fujimoto K, Kawaguchi Y, Wada M, Kogire M, Hosotani R, Imamura M, Uemoto S.
    World J Surg; 2007 Jan 28; 31(1):147-54. PubMed ID: 17171496
    [Abstract] [Full Text] [Related]

  • 17. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS.
    JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival.
    Nizri E, Sternbach N, Bar-David S, Ben-Yehuda A, Gerstenhaber F, Ofir T, Wolf I, Weiner G, Lahat G, Klausner J.
    Ann Surg Oncol; 2018 Feb 10; 25(2):475-481. PubMed ID: 29124488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.